Literature DB >> 8632351

Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.

V A Boundy1, L Lu, P B Molinoff.   

Abstract

By using a baculovirus expression system, the two isoforms of the rat D2 dopamine receptor were expressed at densities ranging up to 15 pmol/mg of protein. D2L and D2S dopamine receptors expressed in aline of Spodoptera frugiperda (Sf9) insect cells Sf9cells, displayed high affinity for the antagonists spiroperidol and (+)-butaclamol and the agonist N-propylnorapomorphine. Antisera raised against the D2 receptor immunoprecipitated binding sites for a radiolabeled D2 antagonist from solubilized extracts of infected Sf9cells. In immunoblots of Sf9cells infected with recombinant D2 baculovirus, these antisera recognized a major species of protein of approximately 46 kDa. Photoaffinity-labeling of infected Sf9cells using N-(p-azido-m-[125I]iodophenethyl)spiperone also identified a protein of this size, suggesting that D2 receptors expressed in Sf9cells are largely unglycosylated. In cells expressing receptors at a density greater than 1 pmol/mg, GTP-sensitive, high-affinity binding of agonists was not detected in studies of the inhibition of the binding of a radiolabeled D2 antagonist. When expression levels were under 1 pmol/mg, the binding of agonists was sensitive to the addition of guanine nucleotides, indicating that D2 receptors were coupled to endogenous G proteins. Endogenous G proteins enable both isoforms of D2 receptors to couple to the inhibition of adenylyl cyclase activity. The high-affinity state of the D2 receptor was directly measured using a radiolabeled agonist. Although the density of receptors increased with longer times after infection, the density of high-affinity sites reached a maximum of approximately 40 fmol/mg 30 to 36 hr after infection. Coexpression of D2 receptors and G protein subunits in Sf9cells dramatically increased the density of high-affinity sites, whereas the total density of receptors was unchanged, confirming that D2 receptors in Sf9 cells can exist in the high-affinity-coupled state, but that appropriate G proteins are expressed at relatively low levels. The density of D2S receptors converted to a coupled, agonist-preferring state when coexpressed with G proteins subunits (alpha i1, beta 1 and gamma 2) was 5 times greater than that of D2L receptors expressed under the same conditions, consistent with the hypothesis that D2 dopamine receptor isoforms differentially couple to alpha i1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632351

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Authors:  Lucien Gazi; Sarah A Nickolls; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.

Authors:  P G Zaworski; G L Alberts; J F Pregenzer; W B Im; J L Slightom; G S Gill
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Specific knockdown of the D2 long dopamine receptor variant.

Authors:  Bart J Naughton; Keerthi Thirtamara-Rajamani; Chuansong Wang; Matthew J During; Howard H Gu
Journal:  Neuroreport       Date:  2012-01-04       Impact factor: 1.837

4.  Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.

Authors:  Y Wang; R Xu; T Sasaoka; S Tonegawa; M P Kung; E B Sankoorikal
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 5.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

6.  Nutrigenomic targeting of carbohydrate craving behavior: can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map?

Authors:  B William Downs; Amanda L C Chen; Thomas J H Chen; Roger L Waite; Eric R Braverman; Mallory Kerner; Dasha Braverman; Patrick Rhoades; Thomas J Prihoda; Tomas Palomo; Marlene Oscar-Berman; Jeffrey Reinking; Seth H Blum; Nicholas A DiNubile; H H Liu; Kenneth Blum
Journal:  Med Hypotheses       Date:  2009-05-17       Impact factor: 1.538

7.  Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.

Authors:  K Blum; M Oscar-Berman; J Giordano; Bw Downs; T Simpatico; D Han; John Femino
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-17

8.  Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality.

Authors:  Kenneth Blum; Marcelo Febo; Claudia Fahlke; Trevor Archer; U Berggren; Zsolt Demetrovics; Kristina Dushaj; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2015-12-17

Review 9.  Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Authors:  Kenneth Blum; Amanda Lih Chuan Chen; Thomas J H Chen; Eric R Braverman; Jeffrey Reinking; Seth H Blum; Kimberly Cassel; Bernard W Downs; Roger L Waite; Lonna Williams; Thomas J Prihoda; Mallory M Kerner; Tomas Palomo; David E Comings; Howard Tung; Patrick Rhoades; Marlene Oscar-Berman
Journal:  Theor Biol Med Model       Date:  2008-11-12       Impact factor: 2.432

10.  The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Authors:  Kenneth Blum; Benjamin Thompson; Zsolt Demotrovics; John Femino; John Giordano; Marlene Oscar-Berman; Scott Teitelbaum; David E Smith; A Kennison Roy; Gozde Agan; James Fratantonio; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Reward Defic Syndr       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.